Mode
Text Size
Log in / Sign up
N/A N=65 Randomized Single-blind Treatment

Nurse Initiated Acupressure for Pain Management

Pain, Postoperative · Pain, Acute

Enrolled (actual)
65
Serious AEs
0.0%
Results posted
Dec 2022
Primary outcome: Primary: Visual Analogue Pain Scale — 3.03; 4.37 units on a scale — p=.048

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Auricular acupressure (Device); Standard of care pain management (Other)
Age
Adult, Older Adult · 18+ yrs
Sex
All
Sponsor
Wake Forest University Health Sciences
Primary completion
Oct 2021

Outcome Measures

OutcomeResultp-value
PRIMARY
Visual Analogue Pain Scale
4.47; 5.80
PRIMARY
Visual Analogue Pain Scale
4.47; 5.80
PRIMARY
Medication Use - Outpatient Opioids
74.2; 88.6 0.64
PRIMARY
Medication Use - Inpatient Opioids
37.8; 35.8 0.86
PRIMARY
Medication Use - Total Other Analgesics
13643; 13766 0.661
SECONDARY
Visual Analogue Pain Scale
4.47; 5.80
SECONDARY
Visual Analogue Pain Scale
4.47; 5.80
SECONDARY
Visual Analogue Pain Scale
4.47; 5.80
SECONDARY
Visual Analogue Pain Scale
4.47; 5.80
SECONDARY
Visual Analogue Pain Scale
4.47; 5.80
SECONDARY
Visual Analogue Pain Scale
4.47; 5.80
SECONDARY
Visual Analogue Pain Scale
4.47; 5.80
SECONDARY
Visual Analogue Pain Scale
4.47; 5.80
SECONDARY
Visual Analogue Pain Scale
4.47; 5.80
SECONDARY
Mean Number of Pellets Retained
7.38
SECONDARY
Number of Participants Who Responded They Were Satisfied With Pain Management
19; 21
SECONDARY
Number of Participants Who Responded "Yes, Would Definitely Consider Using in the Future."
19; 13
SECONDARY
Nurse Time to Deploy Pellets
13.5
SECONDARY
Number of Nurse Concerns Reported
10

Summary

The purpose of pilot study is to test the feasibility of nurse initiated post-operative bilateral auricular acupressure as an adjunct to medication for post-operative pain management.

Eligibility Criteria

Inclusion Criteria

  • Adults 18-80 admitted for knee or hip arthroplasty
  • Pre-surgery morphine equivalent < 50
  • American Society of Anaesthesiologists (ASA) score < 3

Exclusion Criteria

  • Participants with a history of skin disease (psoriasis), adhesive allergy, history of delirium, or cognitive impairment
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT04044716). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search